KR102862249B1 - 치은염을 위한 치료 - Google Patents

치은염을 위한 치료

Info

Publication number
KR102862249B1
KR102862249B1 KR1020247012589A KR20247012589A KR102862249B1 KR 102862249 B1 KR102862249 B1 KR 102862249B1 KR 1020247012589 A KR1020247012589 A KR 1020247012589A KR 20247012589 A KR20247012589 A KR 20247012589A KR 102862249 B1 KR102862249 B1 KR 102862249B1
Authority
KR
South Korea
Prior art keywords
acp
composition
oral
phosphopeptide
acfp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020247012589A
Other languages
English (en)
Korean (ko)
Other versions
KR20240055159A (ko
Inventor
에릭 찰스 레이놀즈
Original Assignee
더 유니버시티 오브 멜버른
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900893A external-priority patent/AU2017900893A0/en
Application filed by 더 유니버시티 오브 멜버른 filed Critical 더 유니버시티 오브 멜버른
Publication of KR20240055159A publication Critical patent/KR20240055159A/ko
Application granted granted Critical
Publication of KR102862249B1 publication Critical patent/KR102862249B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Confectionery (AREA)
KR1020247012589A 2017-03-14 2018-03-14 치은염을 위한 치료 Active KR102862249B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2017900893A AU2017900893A0 (en) 2017-03-14 Treatment for gingivitis
AU2017900893 2017-03-14
KR1020197030173A KR102696078B1 (ko) 2017-03-14 2018-03-14 치은염을 위한 치료
PCT/AU2018/050231 WO2018165708A1 (en) 2017-03-14 2018-03-14 Treatment for gingivitis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197030173A Division KR102696078B1 (ko) 2017-03-14 2018-03-14 치은염을 위한 치료

Publications (2)

Publication Number Publication Date
KR20240055159A KR20240055159A (ko) 2024-04-26
KR102862249B1 true KR102862249B1 (ko) 2025-09-19

Family

ID=63521651

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020247012589A Active KR102862249B1 (ko) 2017-03-14 2018-03-14 치은염을 위한 치료
KR1020197030173A Active KR102696078B1 (ko) 2017-03-14 2018-03-14 치은염을 위한 치료

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197030173A Active KR102696078B1 (ko) 2017-03-14 2018-03-14 치은염을 위한 치료

Country Status (15)

Country Link
US (2) US11717536B2 (enExample)
EP (2) EP4311576A3 (enExample)
JP (1) JP7142943B2 (enExample)
KR (2) KR102862249B1 (enExample)
CN (1) CN110475533A (enExample)
AU (2) AU2018233577B2 (enExample)
CA (1) CA3055091A1 (enExample)
EA (1) EA201991933A1 (enExample)
ES (1) ES2975419T3 (enExample)
MX (1) MX393086B (enExample)
MY (1) MY197428A (enExample)
PH (1) PH12019550157A1 (enExample)
PL (1) PL3595615T3 (enExample)
SG (2) SG10202110136XA (enExample)
WO (1) WO2018165708A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
PL3086751T3 (pl) 2013-12-24 2023-12-27 The University Of Melbourne Stabilizowane kompozycje cyny
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности
WO2025097213A1 (en) * 2023-11-09 2025-05-15 The University Of Melbourne Compositions and methods for treating halitosis

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112A (en) 1847-05-15 Cast-iron car-wheel
US758A (en) 1838-05-30 Mode op
US5968A (en) 1848-12-12 Parlor-stove
US746A (en) 1838-05-25 Improvement in the process of coloring hats, furs
US122A (en) 1837-02-10 Improvement in the machine for weighing heavy bodies
US3864471A (en) 1968-12-20 1975-02-04 Colgate Palmolive Co Stable dentifrices containing a monofluorophosphate, an insoluble metaphosphate, and calcium carbonate
US3966901A (en) 1970-12-29 1976-06-29 Colgate-Palmolive Company Dentifrice preparation
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4157386A (en) 1978-05-18 1979-06-05 Rochelle Paul J Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
US4588763A (en) 1978-06-01 1986-05-13 Braennstroem Martin Ethyl acetate as solvent in cavity liners
NZ199891A (en) 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4357318A (en) 1981-07-31 1982-11-02 Richardson-Vicks Inc. Dentifrices with improved soluble fluoride availability
US4522805A (en) 1983-06-08 1985-06-11 Norman Gordon Tooth and gum dentifrice
US4672032A (en) 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
CA1315480C (en) 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US6056930A (en) 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5227154A (en) 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
EP0651652B1 (en) 1992-06-29 2000-02-09 The University Of Melbourne Treatment for sensitive teeth
CH684773A5 (fr) 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JP3471431B2 (ja) 1994-07-18 2003-12-02 株式会社ジーシー 歯科用グラスアイオノマーセメント組成物
JP3340265B2 (ja) 1994-11-21 2002-11-05 一枝 山岸 歯の漂白剤
KR0140248B1 (ko) 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
ATE206877T1 (de) 1995-06-16 2001-11-15 Nestle Sa Fluorierte kasein-mizellen
US6036944A (en) 1995-08-08 2000-03-14 Enamelon, Inc. Processes for the remineralization and mineralization of teeth
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4040705B2 (ja) 1996-01-24 2008-01-30 株式会社サンギ 口腔組成物
AUPN898296A0 (en) 1996-03-28 1996-04-26 Nulite Systems International Pty Ltd Elastomeric state glass ionomer cement
US5741773A (en) 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
JP2975337B2 (ja) 1997-02-20 1999-11-10 雪印乳業株式会社 カルシウム複合体
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
JPH11228327A (ja) 1998-02-18 1999-08-24 Gc Corp 歯科用ペースト系グラスアイオノマーセメント組成物
JP3742523B2 (ja) 1998-02-27 2006-02-08 雪印乳業株式会社 高分子型カルシウム・ホスホペプチド複合体
US6120754A (en) 1998-03-11 2000-09-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6846500B1 (en) 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
WO2000057842A2 (en) 1999-03-25 2000-10-05 Warner-Lambert Company Oral care chewing gums and confections
FR2791573B1 (fr) 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
US6149894A (en) 1999-05-14 2000-11-21 Colgate Palmolive Company Method for the manufacture of toothpaste
US6521215B2 (en) 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
US6685920B2 (en) 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
JP2001144695A (ja) 1999-11-17 2001-05-25 Matsushita Electric Ind Co Ltd 音声処理装置及び音声処理方法
GB9929919D0 (en) 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
US7727539B2 (en) 2001-03-14 2010-06-01 Drexel University Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
CA2469431C (en) * 2002-01-03 2009-05-26 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
EP1461005A2 (en) 2002-01-03 2004-09-29 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
NZ522071A (en) 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
DE60326998D1 (de) 2002-12-27 2009-05-14 Kao Corp Orale zubereitung
JP3853785B2 (ja) 2002-12-27 2006-12-06 花王株式会社 口腔用組成物
JP4340069B2 (ja) 2003-01-10 2009-10-07 雪印乳業株式会社 カルシウム複合体の製造法
US20050089481A1 (en) 2003-10-23 2005-04-28 Gc Corporation Composition for caries prevention
JP2005145952A (ja) 2003-10-23 2005-06-09 Gc Corp う蝕予防用組成物
US20050118115A1 (en) 2003-10-24 2005-06-02 Fontenot Mark G. Accelerated tooth whitening method, composition and kit
US20060183081A1 (en) 2004-09-27 2006-08-17 Al Bevilacqua Tooth bleaching system and method
EP3192489A1 (en) 2004-11-25 2017-07-19 The University of Melbourne Stabilized calcium phosphate complexes
US7380375B2 (en) 2004-12-14 2008-06-03 Rite-Hite Holding Corporation Alarm system for a loading dock
EP1888014B1 (en) 2005-06-07 2012-11-14 The University of Melbourne Dental mineralization
CN101208070B (zh) 2005-06-24 2011-08-31 墨尔本大学 离子络合物
JP5684454B2 (ja) 2005-11-25 2015-03-11 “ダブリューディーエス” カンパニー 口腔ケア用の治療及び予防組成物
US20070254260A1 (en) 2005-12-02 2007-11-01 Alden Wayne S Iv Oral care compositions, methods, devices and systems
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
US20080171001A1 (en) 2007-01-12 2008-07-17 Engelman Emil E Mineralization toothpaste
PE20130148A1 (es) 2008-02-08 2013-02-11 Colgate Palmolive Co Producto para el cuidado oral y metodos de uso y fabricacion de los mismos
GB0807224D0 (en) 2008-04-21 2008-05-28 Univ Dundee Remineralisation of calcified tissue
US9849310B2 (en) 2008-06-24 2017-12-26 Dental Alliance Holdings, Llc Dental appliance, oral care product and method of preventing dental disease
US9226895B2 (en) 2008-07-30 2016-01-05 Ultradent Products, Inc. Methods and kits for cleaning and remineralizing teeth
JP2010047494A (ja) 2008-08-20 2010-03-04 Gc Corp 歯牙塗布用組成物
JP5437692B2 (ja) * 2009-04-30 2014-03-12 インターコンチネンタル グレート ブランズ エルエルシー チューインガム組成物、チューインガム製品、及びこれらの製造方法
BRPI0924734A2 (pt) 2009-05-18 2016-01-26 Colgate Palmolive Co composição oral, e, métodos para preparar a composição oral, para alvejar um ingrediente ativo, para depositar um material bacteriostático ou bactericida sobre superfícies orais, para retardar ou previnir cárie dentária, método para ocluir túbulos dentinais, para tratar uma lesão por cárie, para calcificar uma polpa de dente exposta, e para calcificar a base de ou a totalidade de um buraco ou de uma fissura em um dente.
JP4693191B2 (ja) 2009-08-06 2011-06-01 日本歯科薬品株式会社 口腔用剤
JP2011073983A (ja) 2009-09-29 2011-04-14 Gc Corp 歯牙塗布用組成物
JP2011162470A (ja) 2010-02-09 2011-08-25 Gc Corp 歯牙用被覆材
SG10201500795WA (en) 2010-02-12 2015-04-29 Theocorp Holding Co Llc Compositions comprising theobromine to improve mechanical strength of teeth
US9539445B2 (en) 2010-11-22 2017-01-10 Taipei Medical University Type of anion-containing calcium phosphate compound for dental remineralization
CN103384526B (zh) 2011-01-24 2017-10-13 巴斯夫欧洲公司 改善口腔健康的组合物
JP2013163656A (ja) 2012-02-10 2013-08-22 Gc Corp 歯磨剤
GB201202341D0 (en) 2012-02-10 2012-03-28 Periproducts Ltd Multicomponent oral care compostion
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
PL3086751T3 (pl) 2013-12-24 2023-12-27 The University Of Melbourne Stabilizowane kompozycje cyny
CN107427700A (zh) 2014-12-24 2017-12-01 墨尔本大学 矿化氟化物组合物
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности
WO2018165708A1 (en) 2017-03-14 2018-09-20 The University Of Melbourne Treatment for gingivitis
MX2021011093A (es) 2019-03-13 2021-12-10 Univ Melbourne Composiciones y metodos para promover la mineralizacion.
CA3133098A1 (en) 2019-03-13 2020-09-17 The University Of Melbourne Concealment of hypomineralised lesions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
British Dental Journal, Vol. 221, pp. 657-666(2016)
Clin. Oral Invest., Vol. 18, pp. 589-598(2014)

Also Published As

Publication number Publication date
CN110475533A (zh) 2019-11-19
SG10202110136XA (en) 2021-10-28
PL3595615T3 (pl) 2024-05-13
ES2975419T3 (es) 2024-07-05
NZ757005A (en) 2023-08-25
SG11201907951QA (en) 2019-09-27
MX393086B (es) 2025-03-24
BR112019018798A2 (pt) 2020-04-07
AU2021269317B2 (en) 2024-05-02
KR20190126141A (ko) 2019-11-08
AU2018233577B2 (en) 2021-08-19
JP7142943B2 (ja) 2022-09-28
US20200054672A1 (en) 2020-02-20
AU2021269317A1 (en) 2021-12-09
CA3055091A1 (en) 2018-09-20
US11717536B2 (en) 2023-08-08
WO2018165708A1 (en) 2018-09-20
EP3595615B1 (en) 2024-01-10
US20240016836A1 (en) 2024-01-18
EP3595615A1 (en) 2020-01-22
EA201991933A1 (ru) 2020-03-05
EP3595615A4 (en) 2020-12-02
JP2020514354A (ja) 2020-05-21
PH12019550157A1 (en) 2020-06-15
EP4311576A3 (en) 2024-04-10
AU2018233577A1 (en) 2019-09-26
EP4311576A2 (en) 2024-01-31
KR20240055159A (ko) 2024-04-26
MY197428A (en) 2023-06-16
MX2019010832A (es) 2019-10-30
KR102696078B1 (ko) 2024-08-16

Similar Documents

Publication Publication Date Title
KR102862249B1 (ko) 치은염을 위한 치료
JP7218934B2 (ja) 安定化第一スズ組成物
EP1888014B1 (en) Dental mineralization
JP2018502099A (ja) 石灰化フルオリド組成物
EA042241B1 (ru) Лечение гингивита
NZ757005B2 (en) Treatment for gingivitis
BR112019018798B1 (pt) Uso de fosfato de cálcio amorfo estabilizado por fosfopeptídeo de caseína e/ou fosfato de cálcio fluoretado amorfo estabilizado por fosfopeptídeo de caseína
Llena et al. Non-cavitated caries lesions: A new approach to medical treatment

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)